Cargando…
Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985240/ https://www.ncbi.nlm.nih.gov/pubmed/31988286 http://dx.doi.org/10.1038/s41408-020-0276-7 |
| _version_ | 1783491779694166016 |
|---|---|
| author | de Mel, Sanjay Rashid, Masturah B. M. Zhang, Xi Yun Goh, Jasmine Lee, Chun Tsu Poon, Li Mei Chan, Esther H. L. Liu, Xin Chng, Wee Joo Chee, Yen Lin Lee, Joanne Yuen, Yi Ching Lim, Jing Quan Chia, Burton K. H. Laurensia, Yurike Huang, DaChuan Pang, Wan Lu Cheah, Daryl Ming Zhe Wong, Esther Kam Yin Ong, Choon Kiat Tang, Tiffany Lim, Soon Thye Ng, Siok Bian Tan, Soo Yong Loi, Hoi-Yin Tan, Lip Kun Chow, Edward K. Jeyasekharan, Anand D. |
| author_facet | de Mel, Sanjay Rashid, Masturah B. M. Zhang, Xi Yun Goh, Jasmine Lee, Chun Tsu Poon, Li Mei Chan, Esther H. L. Liu, Xin Chng, Wee Joo Chee, Yen Lin Lee, Joanne Yuen, Yi Ching Lim, Jing Quan Chia, Burton K. H. Laurensia, Yurike Huang, DaChuan Pang, Wan Lu Cheah, Daryl Ming Zhe Wong, Esther Kam Yin Ong, Choon Kiat Tang, Tiffany Lim, Soon Thye Ng, Siok Bian Tan, Soo Yong Loi, Hoi-Yin Tan, Lip Kun Chow, Edward K. Jeyasekharan, Anand D. |
| author_sort | de Mel, Sanjay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6985240 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69852402020-02-05 Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma de Mel, Sanjay Rashid, Masturah B. M. Zhang, Xi Yun Goh, Jasmine Lee, Chun Tsu Poon, Li Mei Chan, Esther H. L. Liu, Xin Chng, Wee Joo Chee, Yen Lin Lee, Joanne Yuen, Yi Ching Lim, Jing Quan Chia, Burton K. H. Laurensia, Yurike Huang, DaChuan Pang, Wan Lu Cheah, Daryl Ming Zhe Wong, Esther Kam Yin Ong, Choon Kiat Tang, Tiffany Lim, Soon Thye Ng, Siok Bian Tan, Soo Yong Loi, Hoi-Yin Tan, Lip Kun Chow, Edward K. Jeyasekharan, Anand D. Blood Cancer J Correspondence Nature Publishing Group UK 2020-01-27 /pmc/articles/PMC6985240/ /pubmed/31988286 http://dx.doi.org/10.1038/s41408-020-0276-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence de Mel, Sanjay Rashid, Masturah B. M. Zhang, Xi Yun Goh, Jasmine Lee, Chun Tsu Poon, Li Mei Chan, Esther H. L. Liu, Xin Chng, Wee Joo Chee, Yen Lin Lee, Joanne Yuen, Yi Ching Lim, Jing Quan Chia, Burton K. H. Laurensia, Yurike Huang, DaChuan Pang, Wan Lu Cheah, Daryl Ming Zhe Wong, Esther Kam Yin Ong, Choon Kiat Tang, Tiffany Lim, Soon Thye Ng, Siok Bian Tan, Soo Yong Loi, Hoi-Yin Tan, Lip Kun Chow, Edward K. Jeyasekharan, Anand D. Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma |
| title | Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma |
| title_full | Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma |
| title_fullStr | Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma |
| title_full_unstemmed | Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma |
| title_short | Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma |
| title_sort | application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory t-cell lymphoma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985240/ https://www.ncbi.nlm.nih.gov/pubmed/31988286 http://dx.doi.org/10.1038/s41408-020-0276-7 |
| work_keys_str_mv | AT demelsanjay applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT rashidmasturahbm applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT zhangxiyun applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT gohjasmine applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT leechuntsu applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT poonlimei applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT chanestherhl applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT liuxin applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT chngweejoo applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT cheeyenlin applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT leejoanne applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT yuenyiching applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT limjingquan applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT chiaburtonkh applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT laurensiayurike applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT huangdachuan applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT pangwanlu applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT cheahdarylmingzhe applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT wongestherkamyin applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT ongchoonkiat applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT tangtiffany applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT limsoonthye applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT ngsiokbian applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT tansooyong applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT loihoiyin applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT tanlipkun applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT chowedwardk applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma AT jeyasekharananandd applicationofanexvivodrugsensitivityplatformtowardsachievingcompleteremissioninarefractorytcelllymphoma |